Recent Advances in Engineering Iron Oxide Nanoparticles for Effective Magnetic Resonance Imaging
Overview
Affiliations
Iron oxide nanoparticle (IONP) with unique magnetic property and high biocompatibility have been widely used as magnetic resonance imaging (MRI) contrast agent (CA) for long time. However, a review which comprehensively summarizes the recent development of IONP as traditional CA and its new application for different modality of MRI, such as imaging, simultaneous / or MRI/other imaging modality, and as environment responsive CA is rare. This review starts with an investigation of direction on the development of high-performance MRI CA in both and modal based on quantum mechanical outer sphere and Solomon-Bloembergen-Morgan (SBM) theory. Recent rational attempts to increase the MRI contrast of IONP by adjusting the key parameters, including magnetization, size, effective radius, inhomogeneity of surrounding generated magnetic field, crystal phase, coordination number of water, electronic relaxation time, and surface modification are summarized. Besides the strategies to improve or values, strategies to increase the contrast efficiency of IONP have been reviewed from three different aspects, those are introducing second imaging modality to increase the imaging accuracy, endowing IONP with environment response capacity to elevate the signal difference between lesion and normal tissue, and optimizing the interface structure to improve the accumulation amount of IONP in lesion. This detailed review provides a deep understanding of recent researches on the development of high-performance IONP based MRI CAs. It is hoped to trigger deep thinking for design of next generation MRI CAs for early and accurate diagnosis.
Xie D, Sun L, Wu M, Li Q Front Oncol. 2025; 15:1536779.
PMID: 39990682 PMC: 11842268. DOI: 10.3389/fonc.2025.1536779.
Innovative applications of advanced nanomaterials in cerebrovascular imaging.
Na L, Song X, Luo P, Su J, Yao Z Front Bioeng Biotechnol. 2025; 12:1456704.
PMID: 39911816 PMC: 11794002. DOI: 10.3389/fbioe.2024.1456704.
Iron Oxide Nanoparticle-Based T Contrast Agents for Magnetic Resonance Imaging: A Review.
Zhang D, Zhang J, Bian X, Zhang P, Wu W, Zuo X Nanomaterials (Basel). 2025; 15(1.
PMID: 39791792 PMC: 11722098. DOI: 10.3390/nano15010033.
Iron oxide nanoparticles induce ferroptosis under mild oxidative stress in vitro.
Luo C, Li X, Yan H, Guo Q, Liu J, Li Y Sci Rep. 2024; 14(1):31383.
PMID: 39733146 PMC: 11682176. DOI: 10.1038/s41598-024-82917-3.
A CIA strategy with eminent drug-loading capacities for tumor ferroptosis-gas synergistic therapy.
Zhu J, Huang L, Yang J, Li Z, Wu L, Xiong W Theranostics. 2024; 14(19):7349-7369.
PMID: 39659580 PMC: 11626936. DOI: 10.7150/thno.99295.